SSA
EUCRU

Schonfeld Strategic Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-300,000
Closed -$3.2M – 2157
2020
Q4 		$3.2M Buy
+300,000
New +$3.2M 0.04% 476